Hennion & Walsh Asset Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.38M | Sell |
|
|||||
|
2025
Q2 | $2.78M | Buy |
|
|||||
|
2025
Q1 | $2.85M | Buy |
|
|||||
|
2024
Q4 | $2.58M | Buy |
|
|||||
|
2024
Q3 | $2.17M | Buy |
|
|||||
|
2024
Q2 | $1.36M | Buy |
|
|||||
|
2024
Q1 | $480K | Sell |
|
|||||
|
2023
Q4 | $542K | Sell |
|
|||||
|
2023
Q3 | $1.47M | Sell |
|
|||||
|
2023
Q2 | $1.75M | Buy |
|
|||||
|
2023
Q1 | $1.6M | Buy |
|
|||||
|
2022
Q4 | $2.64M | Buy |
|
|||||
|
2022
Q3 | $1.59M | Buy |
|
|||||
|
2022
Q2 | $1.67M | Buy |
|
|||||
|
2022
Q1 | $1.45M | Buy |
|
|||||
|
2021
Q4 | $749K | Buy |
|